1 March 2016 - Health Canada has approved Opdivo (nivolumab) injection, the first and only immuno-oncology therapy (anti PD-1 agent) approved in Canada for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with progression on or after platinum-based chemotherapy.

For more details, go to: http://www.bmscanada.ca/en/news/release/health-canada-approves-opdivo-nivolumab-for-the-treatment-of-advanced-or-metastatic-non-small-cell-l